Illumina Body Map 2: averaged replicates
Name | miRBASE accession |
---|---|
hsa-miR-144-3p
|
MIMAT0000436 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr8_-_91095099 | 2.13 |
ENST00000265431.3
|
CALB1
|
calbindin 1, 28kDa |
chr2_-_161056802 | 1.82 |
ENST00000283249.2
ENST00000409872.1 |
ITGB6
|
integrin, beta 6 |
chr6_+_134210243 | 1.65 |
ENST00000367882.4
|
TCF21
|
transcription factor 21 |
chr5_-_38595498 | 1.57 |
ENST00000263409.4
|
LIFR
|
leukemia inhibitory factor receptor alpha |
chr11_+_130318869 | 1.28 |
ENST00000299164.2
|
ADAMTS15
|
ADAM metallopeptidase with thrombospondin type 1 motif, 15 |
chr9_-_117880477 | 1.27 |
ENST00000534839.1
ENST00000340094.3 ENST00000535648.1 ENST00000346706.3 ENST00000345230.3 ENST00000350763.4 |
TNC
|
tenascin C |
chr8_+_136469684 | 1.24 |
ENST00000355849.5
|
KHDRBS3
|
KH domain containing, RNA binding, signal transduction associated 3 |
chr9_+_132934835 | 1.17 |
ENST00000372398.3
|
NCS1
|
neuronal calcium sensor 1 |
chr9_+_27109133 | 1.15 |
ENST00000519097.1
ENST00000380036.4 |
TEK
|
TEK tyrosine kinase, endothelial |
chr20_-_14318248 | 1.10 |
ENST00000378053.3
ENST00000341420.4 |
FLRT3
|
fibronectin leucine rich transmembrane protein 3 |
chr3_+_178276488 | 1.09 |
ENST00000432997.1
ENST00000455865.1 |
KCNMB2
|
potassium large conductance calcium-activated channel, subfamily M, beta member 2 |
chr7_-_120498357 | 1.08 |
ENST00000415871.1
ENST00000222747.3 ENST00000430985.1 |
TSPAN12
|
tetraspanin 12 |
chr3_+_25469724 | 1.07 |
ENST00000437042.2
|
RARB
|
retinoic acid receptor, beta |
chr16_-_65155833 | 1.06 |
ENST00000566827.1
ENST00000394156.3 ENST00000562998.1 |
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast) |
chr7_-_82073109 | 1.05 |
ENST00000356860.3
|
CACNA2D1
|
calcium channel, voltage-dependent, alpha 2/delta subunit 1 |
chr5_+_52776228 | 1.02 |
ENST00000256759.3
|
FST
|
follistatin |
chr1_-_95392635 | 0.99 |
ENST00000538964.1
ENST00000394202.4 ENST00000370206.4 |
CNN3
|
calponin 3, acidic |
chr3_+_99357319 | 0.98 |
ENST00000452013.1
ENST00000261037.3 ENST00000273342.4 |
COL8A1
|
collagen, type VIII, alpha 1 |
chr3_-_116164306 | 0.89 |
ENST00000490035.2
|
LSAMP
|
limbic system-associated membrane protein |
chr5_+_172068232 | 0.89 |
ENST00000520919.1
ENST00000522853.1 ENST00000369800.5 |
NEURL1B
|
neuralized E3 ubiquitin protein ligase 1B |
chr22_+_29279552 | 0.83 |
ENST00000544604.2
|
ZNRF3
|
zinc and ring finger 3 |
chr1_+_117452669 | 0.82 |
ENST00000393203.2
|
PTGFRN
|
prostaglandin F2 receptor inhibitor |
chr19_-_33555780 | 0.82 |
ENST00000254260.3
ENST00000400226.4 |
RHPN2
|
rhophilin, Rho GTPase binding protein 2 |
chr15_-_48470558 | 0.80 |
ENST00000324324.7
|
MYEF2
|
myelin expression factor 2 |
chr11_-_70507901 | 0.80 |
ENST00000449833.2
ENST00000357171.3 ENST00000449116.2 |
SHANK2
|
SH3 and multiple ankyrin repeat domains 2 |
chr3_+_36421826 | 0.80 |
ENST00000273183.3
|
STAC
|
SH3 and cysteine rich domain |
chr6_-_94129244 | 0.76 |
ENST00000369303.4
ENST00000369297.1 |
EPHA7
|
EPH receptor A7 |
chr9_+_109625378 | 0.74 |
ENST00000277225.5
ENST00000457913.1 ENST00000472574.1 |
ZNF462
|
zinc finger protein 462 |
chr7_-_131241361 | 0.70 |
ENST00000378555.3
ENST00000322985.9 ENST00000541194.1 ENST00000537928.1 |
PODXL
|
podocalyxin-like |
chr15_-_48937982 | 0.70 |
ENST00000316623.5
|
FBN1
|
fibrillin 1 |
chr8_-_42397037 | 0.69 |
ENST00000342228.3
|
SLC20A2
|
solute carrier family 20 (phosphate transporter), member 2 |
chr7_-_27213893 | 0.67 |
ENST00000283921.4
|
HOXA10
|
homeobox A10 |
chr15_-_37390482 | 0.66 |
ENST00000559085.1
ENST00000397624.3 |
MEIS2
|
Meis homeobox 2 |
chr8_-_23712312 | 0.66 |
ENST00000290271.2
|
STC1
|
stanniocalcin 1 |
chr10_+_60272814 | 0.65 |
ENST00000373886.3
|
BICC1
|
bicaudal C homolog 1 (Drosophila) |
chr11_-_115375107 | 0.64 |
ENST00000545380.1
ENST00000452722.3 ENST00000537058.1 ENST00000536727.1 ENST00000542447.2 ENST00000331581.6 |
CADM1
|
cell adhesion molecule 1 |
chr4_+_113970772 | 0.61 |
ENST00000504454.1
ENST00000394537.3 ENST00000357077.4 ENST00000264366.6 |
ANK2
|
ankyrin 2, neuronal |
chr7_+_55086794 | 0.61 |
ENST00000275493.2
ENST00000442591.1 |
EGFR
|
epidermal growth factor receptor |
chr8_-_41166953 | 0.61 |
ENST00000220772.3
|
SFRP1
|
secreted frizzled-related protein 1 |
chr15_+_96873921 | 0.61 |
ENST00000394166.3
|
NR2F2
|
nuclear receptor subfamily 2, group F, member 2 |
chr1_+_2985760 | 0.60 |
ENST00000378391.2
ENST00000514189.1 ENST00000270722.5 |
PRDM16
|
PR domain containing 16 |
chr9_+_118916082 | 0.59 |
ENST00000328252.3
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1 |
chr4_+_106816592 | 0.59 |
ENST00000379987.2
ENST00000453617.2 ENST00000427316.2 ENST00000514622.1 ENST00000305572.8 |
NPNT
|
nephronectin |
chr12_-_88974236 | 0.59 |
ENST00000228280.5
ENST00000552044.1 ENST00000357116.4 |
KITLG
|
KIT ligand |
chr16_-_51185149 | 0.56 |
ENST00000566102.1
ENST00000541611.1 |
SALL1
|
spalt-like transcription factor 1 |
chr12_-_120806960 | 0.56 |
ENST00000257552.2
|
MSI1
|
musashi RNA-binding protein 1 |
chr16_+_86544113 | 0.55 |
ENST00000262426.4
|
FOXF1
|
forkhead box F1 |
chrX_+_105066524 | 0.54 |
ENST00000243300.9
ENST00000428173.2 |
NRK
|
Nik related kinase |
chr5_-_115910630 | 0.53 |
ENST00000343348.6
|
SEMA6A
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
chr1_+_220701456 | 0.52 |
ENST00000366918.4
ENST00000402574.1 |
MARK1
|
MAP/microtubule affinity-regulating kinase 1 |
chr1_+_955448 | 0.52 |
ENST00000379370.2
|
AGRN
|
agrin |
chr7_-_79082867 | 0.52 |
ENST00000419488.1
ENST00000354212.4 |
MAGI2
|
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
chr2_-_213403565 | 0.50 |
ENST00000342788.4
ENST00000436443.1 |
ERBB4
|
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 |
chr14_+_85996471 | 0.49 |
ENST00000330753.4
|
FLRT2
|
fibronectin leucine rich transmembrane protein 2 |
chr2_+_16080659 | 0.48 |
ENST00000281043.3
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog |
chr2_+_14772810 | 0.47 |
ENST00000295092.2
ENST00000331243.4 |
FAM84A
|
family with sequence similarity 84, member A |
chr7_+_20370746 | 0.46 |
ENST00000222573.4
|
ITGB8
|
integrin, beta 8 |
chr4_-_138453606 | 0.46 |
ENST00000412923.2
ENST00000344876.4 ENST00000507846.1 ENST00000510305.1 |
PCDH18
|
protocadherin 18 |
chr1_-_217262969 | 0.46 |
ENST00000361525.3
|
ESRRG
|
estrogen-related receptor gamma |
chr3_-_98620500 | 0.46 |
ENST00000326840.6
|
DCBLD2
|
discoidin, CUB and LCCL domain containing 2 |
chr2_+_159825143 | 0.46 |
ENST00000454300.1
ENST00000263635.6 |
TANC1
|
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 |
chr6_+_107811162 | 0.45 |
ENST00000317357.5
|
SOBP
|
sine oculis binding protein homolog (Drosophila) |
chr11_-_86666427 | 0.45 |
ENST00000531380.1
|
FZD4
|
frizzled family receptor 4 |
chr8_-_42065187 | 0.44 |
ENST00000270189.6
ENST00000352041.3 ENST00000220809.4 |
PLAT
|
plasminogen activator, tissue |
chr8_+_98881268 | 0.43 |
ENST00000254898.5
ENST00000524308.1 ENST00000522025.2 |
MATN2
|
matrilin 2 |
chr16_+_66400533 | 0.43 |
ENST00000341529.3
|
CDH5
|
cadherin 5, type 2 (vascular endothelium) |
chr6_+_17281573 | 0.42 |
ENST00000379052.5
|
RBM24
|
RNA binding motif protein 24 |
chr16_-_10674528 | 0.42 |
ENST00000359543.3
|
EMP2
|
epithelial membrane protein 2 |
chr11_-_27494279 | 0.42 |
ENST00000379214.4
|
LGR4
|
leucine-rich repeat containing G protein-coupled receptor 4 |
chr10_-_15762124 | 0.41 |
ENST00000378076.3
|
ITGA8
|
integrin, alpha 8 |
chr17_+_11144580 | 0.41 |
ENST00000441885.3
ENST00000432116.3 ENST00000409168.3 |
SHISA6
|
shisa family member 6 |
chr6_+_53659746 | 0.41 |
ENST00000370888.1
|
LRRC1
|
leucine rich repeat containing 1 |
chr15_+_80987617 | 0.40 |
ENST00000258884.4
ENST00000558464.1 |
ABHD17C
|
abhydrolase domain containing 17C |
chr13_-_107187462 | 0.40 |
ENST00000245323.4
|
EFNB2
|
ephrin-B2 |
chrX_+_102631248 | 0.40 |
ENST00000361298.4
ENST00000372645.3 ENST00000372635.1 |
NGFRAP1
|
nerve growth factor receptor (TNFRSF16) associated protein 1 |
chr7_+_116312411 | 0.40 |
ENST00000456159.1
ENST00000397752.3 ENST00000318493.6 |
MET
|
met proto-oncogene |
chr17_+_35294075 | 0.39 |
ENST00000254457.5
|
LHX1
|
LIM homeobox 1 |
chr4_-_73434498 | 0.39 |
ENST00000286657.4
|
ADAMTS3
|
ADAM metallopeptidase with thrombospondin type 1 motif, 3 |
chr15_+_84322827 | 0.39 |
ENST00000286744.5
ENST00000567476.1 |
ADAMTSL3
|
ADAMTS-like 3 |
chr3_+_77088989 | 0.38 |
ENST00000461745.1
|
ROBO2
|
roundabout, axon guidance receptor, homolog 2 (Drosophila) |
chr8_+_75896731 | 0.38 |
ENST00000262207.4
|
CRISPLD1
|
cysteine-rich secretory protein LCCL domain containing 1 |
chr9_+_4490394 | 0.36 |
ENST00000262352.3
|
SLC1A1
|
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 |
chr20_-_32891151 | 0.36 |
ENST00000217426.2
|
AHCY
|
adenosylhomocysteinase |
chrX_-_99891796 | 0.36 |
ENST00000373020.4
|
TSPAN6
|
tetraspanin 6 |
chr6_+_121756809 | 0.35 |
ENST00000282561.3
|
GJA1
|
gap junction protein, alpha 1, 43kDa |
chr12_-_31479045 | 0.35 |
ENST00000539409.1
ENST00000395766.1 |
FAM60A
|
family with sequence similarity 60, member A |
chr7_+_116139424 | 0.34 |
ENST00000222693.4
|
CAV2
|
caveolin 2 |
chr5_+_134181625 | 0.34 |
ENST00000394976.3
|
C5orf24
|
chromosome 5 open reading frame 24 |
chr7_+_73442102 | 0.33 |
ENST00000445912.1
ENST00000252034.7 |
ELN
|
elastin |
chr1_+_240255166 | 0.32 |
ENST00000319653.9
|
FMN2
|
formin 2 |
chr7_-_27196267 | 0.32 |
ENST00000242159.3
|
HOXA7
|
homeobox A7 |
chr15_+_38544476 | 0.32 |
ENST00000299084.4
|
SPRED1
|
sprouty-related, EVH1 domain containing 1 |
chr12_-_15942309 | 0.31 |
ENST00000544064.1
ENST00000543523.1 ENST00000536793.1 |
EPS8
|
epidermal growth factor receptor pathway substrate 8 |
chr4_+_183164574 | 0.31 |
ENST00000511685.1
|
TENM3
|
teneurin transmembrane protein 3 |
chr9_-_16870704 | 0.31 |
ENST00000380672.4
ENST00000380667.2 ENST00000380666.2 ENST00000486514.1 |
BNC2
|
basonuclin 2 |
chr22_+_35936915 | 0.30 |
ENST00000216127.4
|
RASD2
|
RASD family, member 2 |
chr9_+_2621798 | 0.30 |
ENST00000382100.3
|
VLDLR
|
very low density lipoprotein receptor |
chr5_+_71403061 | 0.30 |
ENST00000512974.1
ENST00000296755.7 |
MAP1B
|
microtubule-associated protein 1B |
chr12_-_76425368 | 0.29 |
ENST00000602540.1
|
PHLDA1
|
pleckstrin homology-like domain, family A, member 1 |
chr14_-_61190754 | 0.29 |
ENST00000216513.4
|
SIX4
|
SIX homeobox 4 |
chr10_-_79686284 | 0.29 |
ENST00000372391.2
ENST00000372388.2 |
DLG5
|
discs, large homolog 5 (Drosophila) |
chr4_+_8271471 | 0.28 |
ENST00000307358.2
ENST00000382512.3 |
HTRA3
|
HtrA serine peptidase 3 |
chr9_+_133454943 | 0.28 |
ENST00000319725.9
|
FUBP3
|
far upstream element (FUSE) binding protein 3 |
chr8_-_75233563 | 0.27 |
ENST00000342232.4
|
JPH1
|
junctophilin 1 |
chr15_-_83876758 | 0.27 |
ENST00000299633.4
|
HDGFRP3
|
Hepatoma-derived growth factor-related protein 3 |
chr6_+_136172820 | 0.27 |
ENST00000308191.6
|
PDE7B
|
phosphodiesterase 7B |
chr16_-_70719925 | 0.27 |
ENST00000338779.6
|
MTSS1L
|
metastasis suppressor 1-like |
chr7_-_44924939 | 0.27 |
ENST00000395699.2
|
PURB
|
purine-rich element binding protein B |
chr4_+_55524085 | 0.27 |
ENST00000412167.2
ENST00000288135.5 |
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
chr4_+_72204755 | 0.27 |
ENST00000512686.1
ENST00000340595.3 |
SLC4A4
|
solute carrier family 4 (sodium bicarbonate cotransporter), member 4 |
chr4_+_41362796 | 0.27 |
ENST00000508501.1
ENST00000512946.1 ENST00000313860.7 ENST00000512632.1 ENST00000512820.1 |
LIMCH1
|
LIM and calponin homology domains 1 |
chr4_+_134070439 | 0.27 |
ENST00000264360.5
|
PCDH10
|
protocadherin 10 |
chr1_+_110693103 | 0.27 |
ENST00000331565.4
|
SLC6A17
|
solute carrier family 6 (neutral amino acid transporter), member 17 |
chr1_-_225840747 | 0.26 |
ENST00000366843.2
ENST00000366844.3 |
ENAH
|
enabled homolog (Drosophila) |
chr14_-_37642016 | 0.26 |
ENST00000331299.5
|
SLC25A21
|
solute carrier family 25 (mitochondrial oxoadipate carrier), member 21 |
chr12_-_109747023 | 0.26 |
ENST00000355216.1
ENST00000299162.5 |
FOXN4
|
forkhead box N4 |
chr18_-_45663666 | 0.26 |
ENST00000535628.2
|
ZBTB7C
|
zinc finger and BTB domain containing 7C |
chr1_+_176432298 | 0.26 |
ENST00000367661.3
ENST00000367662.3 |
PAPPA2
|
pappalysin 2 |
chr13_+_49550015 | 0.25 |
ENST00000492622.2
|
FNDC3A
|
fibronectin type III domain containing 3A |
chr3_+_32859510 | 0.25 |
ENST00000383763.5
|
TRIM71
|
tripartite motif containing 71, E3 ubiquitin protein ligase |
chr1_+_82266053 | 0.25 |
ENST00000370715.1
ENST00000370713.1 ENST00000319517.6 ENST00000370717.2 ENST00000394879.1 ENST00000271029.4 ENST00000335786.5 |
LPHN2
|
latrophilin 2 |
chr6_-_85474219 | 0.25 |
ENST00000369663.5
|
TBX18
|
T-box 18 |
chr2_-_114036488 | 0.25 |
ENST00000263335.7
ENST00000397647.3 ENST00000348715.5 ENST00000429538.3 |
PAX8
|
paired box 8 |
chr16_+_58059470 | 0.25 |
ENST00000219271.3
|
MMP15
|
matrix metallopeptidase 15 (membrane-inserted) |
chr16_-_57513657 | 0.25 |
ENST00000566936.1
ENST00000568617.1 ENST00000567276.1 ENST00000569548.1 ENST00000569250.1 ENST00000564378.1 |
DOK4
|
docking protein 4 |
chr19_-_47157914 | 0.25 |
ENST00000300875.4
|
DACT3
|
dishevelled-binding antagonist of beta-catenin 3 |
chr15_-_55881135 | 0.25 |
ENST00000302000.6
|
PYGO1
|
pygopus family PHD finger 1 |
chr2_+_56411131 | 0.24 |
ENST00000407595.2
|
CCDC85A
|
coiled-coil domain containing 85A |
chr5_-_176981417 | 0.24 |
ENST00000514747.1
ENST00000443375.2 ENST00000329540.5 |
FAM193B
|
family with sequence similarity 193, member B |
chr9_-_14314066 | 0.24 |
ENST00000397575.3
|
NFIB
|
nuclear factor I/B |
chr6_-_100912785 | 0.24 |
ENST00000369208.3
|
SIM1
|
single-minded family bHLH transcription factor 1 |
chr19_+_51152702 | 0.23 |
ENST00000425202.1
|
C19orf81
|
chromosome 19 open reading frame 81 |
chr7_-_14029515 | 0.23 |
ENST00000430479.1
ENST00000405218.2 ENST00000343495.5 |
ETV1
|
ets variant 1 |
chr12_-_16761007 | 0.23 |
ENST00000354662.1
ENST00000441439.2 |
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
chr8_-_81787006 | 0.23 |
ENST00000327835.3
|
ZNF704
|
zinc finger protein 704 |
chr21_-_27542972 | 0.23 |
ENST00000346798.3
ENST00000439274.2 ENST00000354192.3 ENST00000348990.5 ENST00000357903.3 ENST00000358918.3 ENST00000359726.3 |
APP
|
amyloid beta (A4) precursor protein |
chr9_-_127533519 | 0.22 |
ENST00000487099.2
ENST00000344523.4 ENST00000373584.3 |
NR6A1
|
nuclear receptor subfamily 6, group A, member 1 |
chr12_+_110152033 | 0.21 |
ENST00000538780.1
|
FAM222A
|
family with sequence similarity 222, member A |
chr11_+_69924397 | 0.21 |
ENST00000355303.5
|
ANO1
|
anoctamin 1, calcium activated chloride channel |
chr4_+_126237554 | 0.21 |
ENST00000394329.3
|
FAT4
|
FAT atypical cadherin 4 |
chr2_-_179343268 | 0.21 |
ENST00000424785.2
|
FKBP7
|
FK506 binding protein 7 |
chr9_+_116638562 | 0.21 |
ENST00000374126.5
ENST00000288466.7 |
ZNF618
|
zinc finger protein 618 |
chr7_-_6312206 | 0.20 |
ENST00000350796.3
|
CYTH3
|
cytohesin 3 |
chr15_-_30114622 | 0.20 |
ENST00000495972.2
ENST00000346128.6 |
TJP1
|
tight junction protein 1 |
chr8_-_13372395 | 0.20 |
ENST00000276297.4
ENST00000511869.1 |
DLC1
|
deleted in liver cancer 1 |
chrX_+_76709648 | 0.20 |
ENST00000439435.1
|
FGF16
|
fibroblast growth factor 16 |
chrX_-_54384425 | 0.20 |
ENST00000375169.3
ENST00000354646.2 |
WNK3
|
WNK lysine deficient protein kinase 3 |
chr14_-_81687197 | 0.19 |
ENST00000553612.1
|
GTF2A1
|
general transcription factor IIA, 1, 19/37kDa |
chr10_+_5454505 | 0.19 |
ENST00000355029.4
|
NET1
|
neuroepithelial cell transforming 1 |
chr7_-_81399438 | 0.19 |
ENST00000222390.5
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor) |
chr1_-_182573514 | 0.19 |
ENST00000367558.5
|
RGS16
|
regulator of G-protein signaling 16 |
chr10_+_24755416 | 0.19 |
ENST00000396446.1
ENST00000396445.1 ENST00000376451.2 |
KIAA1217
|
KIAA1217 |
chr12_+_13349650 | 0.19 |
ENST00000256951.5
ENST00000431267.2 ENST00000542474.1 ENST00000544053.1 |
EMP1
|
epithelial membrane protein 1 |
chr3_-_195808952 | 0.18 |
ENST00000540528.1
ENST00000392396.3 ENST00000535031.1 ENST00000420415.1 |
TFRC
|
transferrin receptor |
chr14_-_52535712 | 0.18 |
ENST00000216286.5
ENST00000541773.1 |
NID2
|
nidogen 2 (osteonidogen) |
chr1_+_214161272 | 0.18 |
ENST00000498508.2
ENST00000366958.4 |
PROX1
|
prospero homeobox 1 |
chr6_+_148663729 | 0.17 |
ENST00000367467.3
|
SASH1
|
SAM and SH3 domain containing 1 |
chr2_-_216300784 | 0.17 |
ENST00000421182.1
ENST00000432072.2 ENST00000323926.6 ENST00000336916.4 ENST00000357867.4 ENST00000359671.1 ENST00000346544.3 ENST00000345488.5 ENST00000357009.2 ENST00000446046.1 ENST00000356005.4 ENST00000443816.1 ENST00000426059.1 ENST00000354785.4 |
FN1
|
fibronectin 1 |
chr4_-_103748880 | 0.17 |
ENST00000453744.2
ENST00000349311.8 |
UBE2D3
|
ubiquitin-conjugating enzyme E2D 3 |
chr12_+_93965451 | 0.17 |
ENST00000548537.1
|
SOCS2
|
suppressor of cytokine signaling 2 |
chr2_+_204192942 | 0.17 |
ENST00000295851.5
ENST00000261017.5 |
ABI2
|
abl-interactor 2 |
chr3_-_74570291 | 0.16 |
ENST00000263665.6
|
CNTN3
|
contactin 3 (plasmacytoma associated) |
chr11_-_95522907 | 0.16 |
ENST00000358780.5
ENST00000542135.1 |
FAM76B
|
family with sequence similarity 76, member B |
chr8_-_74884511 | 0.16 |
ENST00000518127.1
|
TCEB1
|
transcription elongation factor B (SIII), polypeptide 1 (15kDa, elongin C) |
chr20_-_47804894 | 0.16 |
ENST00000371828.3
ENST00000371856.2 ENST00000360426.4 ENST00000347458.5 ENST00000340954.7 ENST00000371802.1 ENST00000371792.1 ENST00000437404.2 |
STAU1
|
staufen double-stranded RNA binding protein 1 |
chr15_-_79383102 | 0.15 |
ENST00000558480.2
ENST00000419573.3 |
RASGRF1
|
Ras protein-specific guanine nucleotide-releasing factor 1 |
chr2_-_183903133 | 0.15 |
ENST00000361354.4
|
NCKAP1
|
NCK-associated protein 1 |
chr11_-_95657231 | 0.15 |
ENST00000409459.1
ENST00000352297.7 ENST00000393223.3 ENST00000346299.5 |
MTMR2
|
myotubularin related protein 2 |
chr2_+_166095898 | 0.15 |
ENST00000424833.1
ENST00000375437.2 ENST00000357398.3 |
SCN2A
|
sodium channel, voltage-gated, type II, alpha subunit |
chr15_-_83316254 | 0.15 |
ENST00000567678.1
ENST00000450751.2 |
CPEB1
|
cytoplasmic polyadenylation element binding protein 1 |
chr10_-_128994422 | 0.14 |
ENST00000522781.1
|
FAM196A
|
family with sequence similarity 196, member A |
chr1_+_63063152 | 0.14 |
ENST00000371129.3
|
ANGPTL3
|
angiopoietin-like 3 |
chr6_+_168227611 | 0.14 |
ENST00000344191.4
ENST00000351017.4 ENST00000392108.3 ENST00000366806.2 ENST00000392112.1 ENST00000400824.4 ENST00000447894.2 ENST00000400822.3 |
MLLT4
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 |
chr4_+_144434584 | 0.14 |
ENST00000283131.3
|
SMARCA5
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5 |
chr7_-_155604967 | 0.14 |
ENST00000297261.2
|
SHH
|
sonic hedgehog |
chr3_+_105085734 | 0.14 |
ENST00000306107.5
|
ALCAM
|
activated leukocyte cell adhesion molecule |
chr12_-_56652111 | 0.14 |
ENST00000267116.7
|
ANKRD52
|
ankyrin repeat domain 52 |
chr6_-_99797522 | 0.14 |
ENST00000389677.5
|
FAXC
|
failed axon connections homolog (Drosophila) |
chr12_-_21927736 | 0.14 |
ENST00000240662.2
|
KCNJ8
|
potassium inwardly-rectifying channel, subfamily J, member 8 |
chr8_-_119634141 | 0.14 |
ENST00000409003.4
ENST00000526328.1 ENST00000314727.4 ENST00000526765.1 |
SAMD12
|
sterile alpha motif domain containing 12 |
chr16_+_69221028 | 0.13 |
ENST00000336278.4
|
SNTB2
|
syntrophin, beta 2 (dystrophin-associated protein A1, 59kDa, basic component 2) |
chr1_+_183605200 | 0.13 |
ENST00000304685.4
|
RGL1
|
ral guanine nucleotide dissociation stimulator-like 1 |
chr1_+_199996702 | 0.13 |
ENST00000367362.3
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2 |
chr18_+_8717369 | 0.13 |
ENST00000359865.3
ENST00000400050.3 ENST00000306285.7 |
SOGA2
|
SOGA family member 2 |
chr1_-_242687676 | 0.13 |
ENST00000536534.2
|
PLD5
|
phospholipase D family, member 5 |
chr12_+_51985001 | 0.13 |
ENST00000354534.6
|
SCN8A
|
sodium channel, voltage gated, type VIII, alpha subunit |
chr9_-_14693417 | 0.13 |
ENST00000380916.4
|
ZDHHC21
|
zinc finger, DHHC-type containing 21 |
chr7_-_127032741 | 0.13 |
ENST00000393313.1
ENST00000265827.3 ENST00000434602.1 |
ZNF800
|
zinc finger protein 800 |
chr1_+_200708671 | 0.13 |
ENST00000358823.2
|
CAMSAP2
|
calmodulin regulated spectrin-associated protein family, member 2 |
chr14_+_23790655 | 0.12 |
ENST00000397276.2
|
PABPN1
|
poly(A) binding protein, nuclear 1 |
chr10_-_99393242 | 0.12 |
ENST00000370635.3
ENST00000478953.1 ENST00000335628.3 |
MORN4
|
MORN repeat containing 4 |
chrX_+_146993449 | 0.12 |
ENST00000218200.8
ENST00000370471.3 ENST00000370477.1 |
FMR1
|
fragile X mental retardation 1 |
chr18_-_19180681 | 0.12 |
ENST00000269214.5
|
ESCO1
|
establishment of sister chromatid cohesion N-acetyltransferase 1 |
chr10_+_88516396 | 0.12 |
ENST00000372037.3
|
BMPR1A
|
bone morphogenetic protein receptor, type IA |
chr4_-_129208940 | 0.12 |
ENST00000296425.5
|
PGRMC2
|
progesterone receptor membrane component 2 |
chr4_+_4861385 | 0.11 |
ENST00000382723.4
|
MSX1
|
msh homeobox 1 |
chr12_-_28124903 | 0.11 |
ENST00000395872.1
ENST00000354417.3 ENST00000201015.4 |
PTHLH
|
parathyroid hormone-like hormone |
chr9_-_85678043 | 0.11 |
ENST00000376447.3
ENST00000340717.4 |
RASEF
|
RAS and EF-hand domain containing |
chr13_-_48575443 | 0.11 |
ENST00000378654.3
|
SUCLA2
|
succinate-CoA ligase, ADP-forming, beta subunit |
chr10_-_91403625 | 0.11 |
ENST00000322191.6
ENST00000342512.3 ENST00000371774.2 |
PANK1
|
pantothenate kinase 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.7 | GO:0060435 | branchiomeric skeletal muscle development(GO:0014707) bronchiole development(GO:0060435) |
0.5 | 0.5 | GO:0060458 | right lung development(GO:0060458) |
0.4 | 1.4 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.3 | 1.4 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.3 | 2.5 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
0.2 | 1.6 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 0.9 | GO:0070662 | mast cell proliferation(GO:0070662) |
0.2 | 1.0 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.2 | 0.7 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.2 | 2.0 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.2 | 0.5 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
0.2 | 0.6 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
0.2 | 0.6 | GO:0009956 | radial pattern formation(GO:0009956) |
0.1 | 0.4 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.1 | 0.9 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 1.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 0.5 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.1 | 1.0 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
0.1 | 0.5 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.1 | 0.5 | GO:0061290 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
0.1 | 0.6 | GO:0036371 | protein localization to T-tubule(GO:0036371) |
0.1 | 0.7 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.1 | 0.3 | GO:0051758 | homologous chromosome movement towards spindle pole involved in homologous chromosome segregation(GO:0051758) |
0.1 | 0.6 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 1.5 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.3 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
0.1 | 0.6 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.1 | 0.5 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.1 | 1.1 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 0.4 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.1 | 1.1 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.1 | 0.4 | GO:0010645 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
0.1 | 0.3 | GO:0060827 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
0.1 | 0.2 | GO:1900205 | pronephric field specification(GO:0039003) pattern specification involved in pronephros development(GO:0039017) thyroid-stimulating hormone secretion(GO:0070460) kidney field specification(GO:0072004) regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072304) negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072305) mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) apoptotic process involved in metanephric collecting duct development(GO:1900204) apoptotic process involved in metanephric nephron tubule development(GO:1900205) regulation of apoptotic process involved in metanephric collecting duct development(GO:1900214) negative regulation of apoptotic process involved in metanephric collecting duct development(GO:1900215) regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900217) negative regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900218) mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:1901147) regulation of metanephric DCT cell differentiation(GO:2000592) positive regulation of metanephric DCT cell differentiation(GO:2000594) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
0.1 | 0.3 | GO:1902725 | negative regulation of satellite cell differentiation(GO:1902725) |
0.1 | 0.2 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.1 | 0.4 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.1 | 0.8 | GO:0070836 | caveola assembly(GO:0070836) |
0.1 | 0.4 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) apoptotic process involved in luteolysis(GO:0061364) |
0.1 | 1.1 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.1 | 1.2 | GO:0072178 | nephric duct morphogenesis(GO:0072178) |
0.1 | 1.0 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.1 | 0.2 | GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
0.1 | 0.3 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
0.1 | 0.2 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
0.0 | 0.2 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.0 | 0.2 | GO:0016199 | axon midline choice point recognition(GO:0016199) cellular response to norepinephrine stimulus(GO:0071874) |
0.0 | 0.5 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.0 | 1.0 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.3 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.0 | 0.2 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.0 | 0.1 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
0.0 | 0.3 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.0 | 0.7 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 1.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.1 | GO:0044830 | modulation by host of viral RNA genome replication(GO:0044830) positive regulation of intracellular transport of viral material(GO:1901254) |
0.0 | 0.3 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.0 | 0.1 | GO:0090427 | activation of meiosis(GO:0090427) |
0.0 | 0.1 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.0 | 0.3 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.0 | 0.4 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.0 | 0.4 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.0 | 0.5 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.0 | 0.4 | GO:0070777 | sulfur amino acid transport(GO:0000101) D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 0.2 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.0 | 1.1 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.2 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.0 | 0.3 | GO:0032328 | alanine transport(GO:0032328) |
0.0 | 0.1 | GO:0003186 | tricuspid valve development(GO:0003175) tricuspid valve morphogenesis(GO:0003186) lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) |
0.0 | 0.1 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.0 | 0.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.0 | 0.1 | GO:0061033 | secretion by lung epithelial cell involved in lung growth(GO:0061033) |
0.0 | 0.1 | GO:0006781 | succinyl-CoA pathway(GO:0006781) |
0.0 | 0.2 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.0 | 0.3 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.0 | 0.6 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.0 | 0.1 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.0 | 0.8 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.3 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.0 | 0.1 | GO:0072720 | response to dithiothreitol(GO:0072720) |
0.0 | 0.7 | GO:0060065 | uterus development(GO:0060065) |
0.0 | 0.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.0 | 0.8 | GO:0071625 | vocalization behavior(GO:0071625) |
0.0 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.0 | 0.0 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.0 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.6 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.0 | 0.2 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.3 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.0 | 0.1 | GO:0019085 | early viral transcription(GO:0019085) |
0.0 | 0.2 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.0 | 0.0 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
0.0 | 0.2 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.1 | GO:0051414 | response to cortisol(GO:0051414) |
0.0 | 0.4 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.1 | GO:0072660 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.0 | 0.2 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.0 | 0.0 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.0 | 1.2 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.0 | 0.3 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.0 | GO:0003099 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.0 | 0.3 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.0 | 0.8 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.0 | 0.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.0 | 0.4 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.4 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.0 | 0.3 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.1 | GO:1902731 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) negative regulation of chondrocyte proliferation(GO:1902731) |
0.0 | 0.5 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.0 | 0.0 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.0 | 0.1 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.0 | 0.3 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.0 | 0.1 | GO:0033504 | floor plate development(GO:0033504) |
0.0 | 0.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.0 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.0 | 0.1 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
0.0 | 0.1 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.8 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.2 | 0.5 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.2 | 0.6 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
0.2 | 1.0 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
0.1 | 1.0 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.1 | 1.2 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 1.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 0.8 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.1 | GO:1902737 | dendritic filopodium(GO:1902737) |
0.0 | 1.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.1 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
0.0 | 1.2 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.1 | GO:0031213 | RSF complex(GO:0031213) |
0.0 | 0.2 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.0 | 0.3 | GO:0071953 | elastic fiber(GO:0071953) |
0.0 | 1.6 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.4 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.0 | 1.1 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.2 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.3 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.0 | 0.6 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.0 | 1.4 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.4 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 1.9 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 2.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 0.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 1.6 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.4 | GO:0030673 | axolemma(GO:0030673) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.6 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
0.3 | 1.0 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
0.3 | 2.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 0.9 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 1.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.6 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 1.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.4 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 0.8 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 0.5 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 2.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.5 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.7 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 0.3 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
0.1 | 1.6 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 1.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.2 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.1 | 0.4 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 1.5 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.8 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.4 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
0.0 | 0.4 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.0 | 0.2 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.0 | 0.1 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.0 | 0.1 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
0.0 | 1.1 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.2 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.2 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 0.2 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.0 | 1.0 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 1.7 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.1 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.0 | 1.2 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.2 | GO:0051425 | PTB domain binding(GO:0051425) |
0.0 | 0.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 0.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.2 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.0 | 0.8 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 2.2 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.1 | GO:0001047 | core promoter binding(GO:0001047) |
0.0 | 0.2 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.0 | 1.3 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.0 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.1 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.0 | 0.0 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.0 | 0.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.0 | 0.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.6 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.0 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.1 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.0 | 0.1 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
0.0 | 0.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.0 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.1 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.0 | 0.1 | GO:0071253 | connexin binding(GO:0071253) |
0.0 | 0.0 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.7 | GO:0030507 | spectrin binding(GO:0030507) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 1.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 1.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 1.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.9 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 1.5 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.8 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.5 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.4 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.5 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.6 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.0 | 1.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 1.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 4.8 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.5 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 0.6 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 1.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.5 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.0 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.0 | 0.2 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.4 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |